首页> 外文期刊>VINE journal of information and knowledge management systems >Anthelmintic therapy of equine cyathostomin nematodes – larvicidal efficacy, egg reappearance period, and drug resistance
【24h】

Anthelmintic therapy of equine cyathostomin nematodes – larvicidal efficacy, egg reappearance period, and drug resistance

机译:αsthelmintic治疗大二胆汁线虫 - 幼虫疗效,卵再造成期和耐药性

获取原文
获取原文并翻译 | 示例
           

摘要

ublishercopyright>? 2017 Australian Society for Parasitology? 2017 Australian Society for Parasitology Cyathostomins are ubiquitous in grazing horses across the world, and anthelmintic resistance has been reported with increasing levels over past decades. The aims of the present study were (i) to investigate the efficacy against encysted larval stages of moxidectin (0.4 mg/kg) and fenbendazole (10 mg/kg daily for five consecutive days) and compare these regimens at 2 and 5 weeks post-treatment, (ii) to investigate individual cyathostomin species associated with shortened egg reappearance periods, and (iii) to document species exhibiting decreased susceptibility to the evaluated compounds. Thirty-six ponies were allocated to treatment groups with half euthanatized 2 weeks post-treatment, and the remainder necropsied after 5 weeks. Luminal and mucosal worm counts were conducted and strongyle egg counts were determined at weekly intervals. At 2 weeks, mean reductions of early L3s were 50.4% and 73.8% for fenbendazole and moxidectin, respectively. At 5 weeks, the respective efficacies were 51.3% and 71.8%. Two week efficacies against late L3s and L4s (LL3s/L4s) were 70.8% and 74.6% for fenbendazole and moxidectin, respectively, whereas very low numbers were found in all three groups at 5 weeks. None of the mucosal counts were significantly different between treatment groups. Fenbendazole and moxidectin reduced luminal worm counts by 93.2% and 98.3% at 2 weeks following administration, with moxidectin group adult counts being significantly lower than the other two groups (P 0.0001). Both treatment groups had increased counts 3 weeks later (P = 0.0415). A moxidectin ERP of 4 weeks was associated with surviving luminal L4s, and adult species contributing to this were Cyathostomum catinatum, Cylicostephanus longibursatus, Cylicocyclus ashworthi and Cylicocyclus nassatus. This study documented (i) larvicidal efficacy of fenbendazole much lower than historical standards, (ii) survival of luminal immatures (L4) following moxidectin administration, and (iii) new information about cyathostomin species associated with these phenomena.Cyathostomins are ubiquitous in grazing horses across the world, and anthelmintic resistance has been reported with increasing levels over past decades. The aims of the present study were (i) to investigate the efficacy against encysted larval stages of moxidectin (0.4 mg/kg) and fenbendazole (10 mg/kg daily for five consecutive days) and compare these regimens at 2 and 5 weeks post-treatment, (ii) to investigate individual cyathostomin species associated with shortened egg reappearance periods, and (iii) to document species exhibiting decreased susceptibility to the evaluated compounds. Thirty-six ponies were allocated to treatment groups with half euthanatized 2 weeks post-treatment, and the remainder necropsied after 5 weeks. Luminal and mucosal worm counts were conducted and strongyle egg counts were determined at weekly intervals. At 2 weeks, mean reductions of early L3s were 50.4% and 73.8% for fenbendazole and moxidectin, respectively. At 5 weeks, the respective efficacies were 51.3% and 71.8%. Two week efficacies against late L3s and L4s (LL3s/L4s) were 70.8% and 74.6% for fenbendazole and moxidectin, respectively, whereas very low numbers were found in all three groups at 5 weeks. None of the mucosal counts were significantly different between treatment groups. Fenbendazole and moxidectin reduced luminal worm counts by 93.2% and 98.3% at 2 weeks following administration, with moxidectin group adult counts being significantly lower than the other two groups (P < 0.0001). Both treatment groups had increased counts 3 weeks later (P = 0.0415). A moxidectin ERP of 4 weeks was associated with surviving luminal L4s, and adult species contributing to this were Cyathostomum catinatum, Cylicostephanus longibursatus, Cylicocyclus ashworthi and Cylicoc
机译:ublishercopyright>? 2017澳大利亚寄生虫学会? 2017年澳大利亚寄生学协会 cyathostomins在世界各地吃草的马匹普遍存在,据报道,过去几十年的水平越来越多。本研究的目的是(i)探讨对莫克利菌蛋白(0.4mg / kg)和Fenbendazole的幼虫阶段的疗效(连续5天每天10 mg / kg),并在2和5周后比较这些方案治疗(ii)研究与缩短的蛋再生时期相关的个体胞质素物种,(iii)对表现出对评估化合物的易感性降低的文献物种。分配了三十六个小袋,治疗组,后治疗2周为2周,5周后剩下的尸检。进行了腔和粘膜蠕虫计数,并按每周间隔测定鸡蛋计数。在2周内,分别平均降低L3s的平均降低为Fenbendazole和莫克利菌素的50.4%和73.8%。在5周,各自的效率为51.3%和71.8%。对于L3S和L4S(LL3S / L4)的两周效率分别为芬邦沙唑和莫克利菌素的70.8%和74.6%,而在5周内在所有三组中发现非常低的数量。在治疗组之间没有粘膜计数无显着差异。在给药后2周内,Fenbendazole和Moxidectin减少了93.2%和98.3%,偏霉素组成人计数明显低于其他两组(P <0.0001)。两个治疗组3周后两次数量增加(P = 0.0415)。 4周的杀虫病ERP与存活的腔L4s有关,成人物种是Cyathostomum catinatum,CythiCostephanus longibursatus,Cylicconcclus Ashworthi和Cyricoccyclus Nassatus。本研究记录了(i)Fenbendazole的幼稚疗效远低于历史标准,(ii)在莫克利菌蛋白给药后的腔内不定(L4)的存活率,以及(iii)关于与这些现象相关的细胞瘤物种的新信息。 Cyathostomins普遍存在于世界上的牧草,据报道,过去几十年的水平越来越多。本研究的目的是(i)探讨对莫克利菌蛋白(0.4mg / kg)和Fenbendazole的幼虫阶段的疗效(连续5天每天10 mg / kg),并在2和5周后比较这些方案治疗(ii)研究与缩短的蛋再生时期相关的个体胞质素物种,(iii)对表现出对评估化合物的易感性降低的文献物种。分配了三十六个小袋,治疗组,后治疗2周为2周,5周后剩下的尸检。进行了腔和粘膜蠕虫计数,并按每周间隔测定鸡蛋计数。在2周内,分别平均降低L3s的平均降低为Fenbendazole和莫克利菌素的50.4%和73.8%。在5周,各自的效率为51.3%和71.8%。对于L3S和L4S(LL3S / L4)的两周效率分别为芬邦沙唑和莫克利菌素的70.8%和74.6%,而在5周内在所有三组中发现非常低的数量。在治疗组之间没有粘膜计数无显着差异。在给药后2周内,Fenbendazole和Moxidectin减少了93.2%和98.3%,偏霉菌蛋白基团成年计数显着低于其他两组(P <0.0001)。两个治疗组3周后两次数量增加(P = 0.0415)。 4周的杀虫病ERP与存活的Luminal L4s相关,成人物种是Cyathostomum catinatum,CyliCostephanus longibursatus,Cylicoccyclus Ashworthi和Cylizoc

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号